The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Lopac-C-117     3-(2-aminoethyl)-1H-indole-5- carboxamide

Synonyms: Tocris-0458, CHEMBL18840, AG-A-50002, AG-J-15141, SureCN2677791, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lopac-C-117


Psychiatry related information on Lopac-C-117


High impact information on Lopac-C-117


Biological context of Lopac-C-117


Anatomical context of Lopac-C-117


Associations of Lopac-C-117 with other chemical compounds


Gene context of Lopac-C-117


Analytical, diagnostic and therapeutic context of Lopac-C-117


  1. No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Hedlund, P.B., Danielson, P.E., Thomas, E.A., Slanina, K., Carson, M.J., Sutcliffe, J.G. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  2. The mechanism by which epinastine stops an adenosine analog from contracting BDE rat airways. Meade, C.J. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  3. A 5-HT1-like receptor mediates a sympathetic ganglionic hyperpolarization. Gilbert, M.J., Newberry, N.R. Eur. J. Pharmacol. (1987) [Pubmed]
  4. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area. Gillies, D.M., Mylecharane, E.J., Jackson, D.M. Eur. J. Pharmacol. (1996) [Pubmed]
  5. Effects of serotonin and serotonin analogs on posture and agonistic behavior in crayfish. Tierney, A.J., Mangiamele, L.A. J. Comp. Physiol. A (2001) [Pubmed]
  6. Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Lovenberg, T.W., Erlander, M.G., Baron, B.M., Racke, M., Slone, A.L., Siegel, B.W., Craft, C.M., Burns, J.E., Danielson, P.E., Sutcliffe, J.G. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  7. Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. McAllister, G., Charlesworth, A., Snodin, C., Beer, M.S., Noble, A.J., Middlemiss, D.N., Iversen, L.L., Whiting, P. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  8. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. Esterle, T.M., Sanders-Bush, E. J. Neurosci. (1992) [Pubmed]
  9. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. Beg, S.S., Hansen-Schwartz, J.A., Vikman, P.J., Xu, C.B., Edvinsson, L.I. J. Cereb. Blood Flow Metab. (2007) [Pubmed]
  10. ERK1/2 inhibition attenuates cerebral blood flow reduction and abolishes ET(B) and 5-HT(1B) receptor upregulation after subarachnoid hemorrhage in rat. Beg, S.A., Hansen-Schwartz, J.A., Vikman, P.J., Xu, C.B., Edvinsson, L.I. J. Cereb. Blood Flow Metab. (2006) [Pubmed]
  11. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor. Zgombick, J.M., Schechter, L.E., Macchi, M., Hartig, P.R., Branchek, T.A., Weinshank, R.L. Mol. Pharmacol. (1992) [Pubmed]
  12. 5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Saxena, P.R., Verdouw, P.D. Br. J. Pharmacol. (1985) [Pubmed]
  13. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro. Corradetti, R., Le Poul, E., Laaris, N., Hamon, M., Lanfumey, L. J. Pharmacol. Exp. Ther. (1996) [Pubmed]
  14. Functional characterization of the recombinant human 5-hydroxytryptamine7(a) receptor isoform coupled to adenylate cyclase stimulation. Adham, N., Zgombick, J.M., Bard, J., Branchek, T.A. J. Pharmacol. Exp. Ther. (1998) [Pubmed]
  15. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. Nilsson, T., Longmore, J., Shaw, D., Olesen, I.J., Edvinsson, L. Br. J. Pharmacol. (1999) [Pubmed]
  16. 5-Hydroxytryptamine1A and 5-hydroxytryptamine1B receptors stimulate [35S]guanosine-5'-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography. Waeber, C., Moskowitz, M.A. Mol. Pharmacol. (1997) [Pubmed]
  17. Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex. Galzin, A.M., Poirier, M.F., Lista, A., Chodkiewicz, J.P., Blier, P., Ramdine, R., Loô, H., Roux, F.X., Redondo, A., Langer, S.Z. J. Neurochem. (1992) [Pubmed]
  18. Differential effects of stress on presynaptic and postsynaptic 5-hydroxytryptamine-1A receptors in the rat brain: an in vitro electrophysiological study. Laaris, N., Le Poul, E., Laporte, A.M., Hamon, M., Lanfumey, L. Neuroscience (1999) [Pubmed]
  19. Effects of 5-HT receptor agonists on depolarization-induced [3H]-noradrenaline release in rabbit hippocampus and human neocortex. Allgaier, C., Warnke, P., Stangl, A.P., Feuerstein, T.J. Br. J. Pharmacol. (1995) [Pubmed]
  20. Comparison of the response to 5-carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. Toda, N., Okamura, T. J. Pharmacol. Exp. Ther. (1990) [Pubmed]
  21. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. Cohen, Z., Bouchelet, I., Olivier, A., Villemure, J.G., Ball, R., Stanimirovic, D.B., Hamel, E. J. Cereb. Blood Flow Metab. (1999) [Pubmed]
  22. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Dumuis, A., Bouhelal, R., Sebben, M., Cory, R., Bockaert, J. Mol. Pharmacol. (1988) [Pubmed]
  23. Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5-HT 1A autoreceptors in mice. Guiard, B.P., Froger, N., Hamon, M., Gardier, A.M., Lanfumey, L. J. Neurochem. (2005) [Pubmed]
  24. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. Schoeffter, P., Hoyer, D. J. Pharmacol. Exp. Ther. (1990) [Pubmed]
  25. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells. Dickenson, J.M., Hill, S.J. Eur. J. Pharmacol. (1996) [Pubmed]
  26. Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1D receptors. Fink, K., Zentner, J., Göthert, M. Naunyn Schmiedebergs Arch. Pharmacol. (1995) [Pubmed]
  27. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice. Sarhan, H., Grimaldi, B., Hen, R., Fillion, G. Naunyn Schmiedebergs Arch. Pharmacol. (2000) [Pubmed]
  28. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors. Ng, N.K., Lee, H.S., Wong, P.T. J. Neurosci. Res. (1999) [Pubmed]
  29. Interaction of serotonergic excitatory drive to hypoglossal motoneurons with carbachol-induced, REM sleep-like atonia. Kubin, L., Tojima, H., Reignier, C., Pack, A.I., Davies, R.O. Sleep. (1996) [Pubmed]
  30. Characterization of prejunctional 5-HT1 receptors that mediate the inhibition of pressor effects elicited by sympathetic stimulation in the pithed rat. Morán, A., Fernández, M.M., Velasco, C., Martín, M.L., San Román, L. Br. J. Pharmacol. (1998) [Pubmed]
  31. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation. Fernández, M.M., Morán, A., Martín, M.L., San Román, L. Eur. J. Pharmacol. (2000) [Pubmed]
  32. 5-Hydroxytryptamine receptor subtypes participating in pulmonary edema in dogs. Sumita, T., Ishikawa, N., Hashiba, Y., Takagi, K., Satake, T. Eur. J. Pharmacol. (1989) [Pubmed]
  33. 5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved? Verbeuren, T.J., Mennecier, P., Laubie, M. Eur. J. Pharmacol. (1991) [Pubmed]
WikiGenes - Universities